There were 1,870 press releases posted in the last 24 hours and 358,822 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image